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Objective To identify morning salivary cortisol reference values in infancy and at 2 years of age and to investi-
gate the influence of age, sex and acute bronchiolitis.
Study design In this South-East Norwegian cohort study, 308 children hospitalized with moderate to severe acute
bronchiolitis in infancy in 2010-2011 were compared with 223 healthy controls included in 2012 by measuring morning
salivary cortisol levels at inclusion and at 2 years of age. Samples were collected shortly after awakening after 6
AM. The influences of age, sex, and acute bronchiolitis were assessed by regression analysis.
Results In infancy, cortisol values were higher in acute bronchiolitis, with an age- and sex-adjusted weighted mean
group difference of 13.9 nmol/L (95% CI 8.1-19.7; P < .0001). The median level in reference group was 23.7 nmol/L
(95% CI 9.7-119.6). At 2 years of age, sex but not inclusion groups differed, with significantly higher values in girls.
The weighted mean of all boys’ cortisol levels was 32.4 nmol/L, (95% CI 30.5-34.3), and all girls’ levels were 36.9 nmol/L
(95% CI 34.7-39.2; P < .003).
Conclusions Salivary cortisol levels were higher at 2 years of age than in infancy in the reference group, were
higher in girls than in boys at 2 years of age, and were higher in infants at the time of acute bronchiolitis than in
healthy infants. (J Pediatr 2017;184:193-8).
Trial registration ClinicalTrials.gov: NCT00817466
Cortisol levels normally show a circadian rhythm with physiologically increased levels in the morning, with an addi-tional cortisol awakening response.1,2 Cortisol levels can be analyzed in blood, urine, and saliva.3-5 Salivary samples arenoninvasive, and do not induce the trauma, stress, and potentially higher cortisol compared with serum sampling.6
However, a potential shortcoming of salivary measurement is the issue of spot sampling of a biomarker with known diurnal
variation.7 There are few reports on reference values of morning salivary cortisol levels in infants and toddlers, reflecting the
biologically active, free fraction of serum cortisol.8-10
Reduced morning cortisol has been associated with allergic diseases such as asthma and allergic rhinitis in young and older
children, pointing to an involvement of adrenocortical function.11-14
Links between stress, cortisol levels, and asthma in early childhood or later asthma development have been proposed,14-16
and we recently showed that being hospitalized for acute bronchiolitis in infancy increased the risk for reduced health-related
quality of life.17 However, investigation of possible causal associations between infant salivary cortisol levels and later asthma
requires relevant reference values of morning salivary cortisol levels in early childhood.
Our primary aim was to describe reference values for morning salivary cortisol levels during infancy and at 2 years of age.
Second, we sought to investigate whether age, sex, or acute moderate to severe bronchiolitis in infancy influenced morning sali-
vary cortisol levels.
Methods
The present study included 531 children with at least 1 (total 762) salivary cor-
tisol level measurement in infancy, when they were recruited into the study and/
or at the 2-year follow-up (Figure 1; available at www.jpeds.com). The source
population included 404 infants hospitalized with moderate to severe acute bron-
chiolitis in 8 pediatric departments of southeast Norway. Additionally, 240 infants
were recruited by postal invitation to 3000 randomly selected children 0-12 months
of age from the municipalities of Oslo and Fredrikstad17 from March 22, 2012 to
July 2, 2012, who were included in the Bronchiolitis ALL SE-Norway study
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(hereafter referred to as the Bronchiolitis study).18 As previ-
ously reported, respiratory syncytial virus (RSV) was identi-
fied in 83% and human rhinovirus in 34% of participants; 44%
received oxygen therapy and 7.4% received ventilatory
support.18,19 The follow-up investigation at 2 years, per-
formed from September 27, 2011, to December 14, 2011, Sep-
tember 11, 2012 to December 18, 2012, and October 7, 2013
to January 22, 2014, was attended by 499 of the initial 644
infants (77.5%).
Inclusion criteria for all infants were age 0-12 months,
and for inclusion into the Bronchiolitis study, moderate to
severe bronchiolitis, with a clinical score of at least 4 on a
scale from 0 to 10 (most severe).18 Exclusion criteria for all
infants were severe underlying disease, and for the Bronchi-
olitis study, more than one episode of either bronchopulmonary
obstruction or cough lasting for longer than 4 weeks before
recruitment.
Procedures
Clinical investigations, morning cortisol sampling, and pa-
rental structured interviews were conducted at inclusion and
at 2 years of age.
The study was approved by the Regional Committee for
Medical and Health Research Ethics and The Norwegian Data
Protection Authority and was registered in the Norwegian bio
bank registry as well as ClinicalTrials.gov number,
NCT00817466. Written informed consent was obtained from
caregivers of all children.
Saliva Sampling
Parents were instructed to sample saliva in the morning as
soon as possible after the child’s awakening (after 6:00 a.m.)
and before the children’s first meal. Two small (0.7 × 1.8 mm),
tasteless, arrowhead-shaped Sorbette (hydrocellulose, Salimetrics
Europe Ltd, Suffolk, UK) microsponges attached to plastic
applicator shafts were inserted into the child’s mouth,
preferably under the tongue, and kept there for a total of
60-90 seconds, until the microsponges were soaked with
saliva.20 The salivary samples in their respective standard
containers were brought to the investigation site, and
thereafter frozen at −86°C until transferal to Karolinska
Institutet, Stockholm, for analysis. Radioimmunoassay was
performed according to the manufacturer’s instructions
using kits from Cisbio Bioassays (Codolet, France) with
monoclonal rabbit antibodies binding cortisol. For further
description, see the Appendix (available at www.jpeds.com).
The assay is standardized against the reference method, mass
spectrometry.
Main Outcome
Reference values were defined as salivary cortisol levels (nmol/
L) ranging from the 5th to the 95th percentile in infancy (at
inclusion) and at 2 years of age. For comparison with other
studies, geometric means were estimated and reported. Sec-
ondary outcomes for assessing potential influence of age, sex,
and acute bronchiolitis were weighted mean salivary cortisol
levels (nmol/L) with 95% CI.
Statistical Analyses
Background characteristics are given as means with SD, mean
with minimum and maximum, or numbers with percent-
ages, as appropriate. Neither morning salivary cortisol levels
nor their natural logarithms were normally distributed. Per-
centiles including 95% CI for the 5th and 95th percentiles were
used for estimating reference values.
To assess the potential impact of age, sex, and hospitaliza-
tion for acute bronchiolitis on morning salivary cortisol
levels, associations with cortisol were examined by the Huber
M method of regression analysis,21 whereas associations between
dichotomous variables were analyzed by Pearson c2 test.
Weighted means were calculated by Huber M regression
methods, applying groups as categorical values, and estimat-
ing intercepts as the weighted mean. The significance level
was set at .05. Interaction between age, sex, and morning
salivary cortisol was tested by 2-way robust regression. Per-
centile analyses and robust regression analyses were done
with NCSS 2007 (NCSS Statistical Software, Kaysville, Utah);
otherwise, IBM SPSS (SPSS Inc, Chicago, Illinois) version
22.
Results
Salivary samples were obtained from January 15, 2010, to
May 20, 2011, from 383 infants at a mean age of 5.1 months
(range 0.2-13.4) and from 379 children at a mean age of 24.2
months (range 17.2-34.7; Table I), with samples at both time
points in 231 children and on 1 occasion in the remaining
300 children (Figure 1). Background characteristics were similar
between children from the reference group and bronchiolitis
group with respect to sex, age at 2 years, parental asthma,
ethnicity, and breast feeding, but significantly different with
respect to weight and length, parental education, and use of
inhaled corticosteroids (Table I). No interaction was found
between age, sex, or morning salivary cortisol at the 2 time
points.
Morning salivary cortisol ranged from 1.9 to 691.4 nmol/L
in infancy and from 2.5 to 189.0 nmol/L at 2 years of age.
Reference Values
In infancy, the reference group had a geometric mean of
26.8 (95% CI 24.0-30.0) nmol/L with the reference values
given by percentiles (Table II). The bronchiolitis group had
significantly higher cortisol values (Figures 2-4; Figures 2
and 3 available at www.jpeds.com), with a geometric mean
of 37.0 nmol/L (95% CI 33.0-41.4) and a median of
39.9 nmol/L.
At 2 years of age, the weighted mean cortisol values were
similar in the control and bronchiolitis groups. Reference values
were therefore based on values including all children (Table II;
Figures 5 and 6, available at www.jpeds.com), with a geomet-
ric mean of 32.1 nmol/L (95% CI 30.4-33.9).
Cortisol levels were above 3 SD in 1.5% and in 1.9% of
the children at inclusion and at 2 years of age, respectively.
By robust regression, we found no association or individual
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repeatability between salivary cortisol at inclusion and at
2 years of age in any of the groups, with a regression
coefficient of 0.001 (P = .93) in the reference group and a
regression coefficient of −0.010 (P = .83) in the bronchiolitis
group.
The Role of Age and Sex
The weighted mean cortisol in the reference group was
significantly higher at age 2 years (34.9 nmol/L; 95% CI
32.6-37.2) than in infancy (28.7 nmol/L; 95% CI 25.1-32.4)
with a difference of 7.8 nmol/L (95% CI 2.4-13.1; P = .004),
whereas the reverse was found in the bronchiolitis group
at age 2 years (33.8 nmol/L; 95% CI 31.8-35.7) vs infancy
(41.5 nmol/L; 95% CI 37.6-45.4), with a difference of
−6.4 nmol/L (95% CI −11.0, −1.8; P = .006). Sex-stratified
results are shown in Figures 3 and 6.
However, increasing age within infancy or at 2 years of age
was not associated with cortisol levels in regression analyses
(Table III; available at www.jpeds.com).
At 2 years of age (but not in infancy), girls had signifi-
cantly higher weighted mean and geometric mean morning
salivary cortisol compared with boys (Figures 6 and 7
Table I. Background characteristics of the 531 children with cortisol results during infancy, at 2 years of age, at either
or both times
Reference group Bronchiolitis group P value
All subjects (n = 531) 223 308
Boys, n (%) 125 (56.1%) 186 (60.4%) .317
Age (mo), mean (min–max)
Inclusion (n = 531) 6.5 (1.0-13.4) 4.1 (0.2-11.9) <.001
Two years of age (n = 453) 24.2 (17.2-34.7) 24.3 (18.8-34.7) .667
Time (mo) between visit 1 and 2 (n = 379) 17.7 (1.2) 20.0 (1.2) <.001
Weight (kg), mean (SD)
Inclusion (n = 518) 7.9 (1.8) 6.5 (1.8) <.001
Two years of age (n = 433) 12.9 (1.6) 13.2 (1.7 .05
Length (cm), mean (SD)
Inclusion (n = 371) 67.8 (6.4) 62.9 (6.8) <.001
Two years of age (n = 434) 88.6 (4.4) 87.1 (4.1) <.001
Parental asthma (n = 520), n (%) 86 (29.6%) 94 (31.6%) .632
Parental allergic rhinitis (n = 527), n (%) 84 (37.7%) 89 (29.3%) .049
High education, n (%)*
Mothers (n = 483) 199 (89.2%) 71 (63.3%) <.001
Fathers (n = 487) 179 (81.4%) 150 (56.2%) <.001
Caucasian, n (%)
Mothers (n = 495) 211 (94.6%) 254 (93.4%) .566
Fathers (n = 491) 206 (92.4%) 252 (94.0%) .466
Breastfed, n (%)
Inclusion (n = 453) 148 (75.1%) 187 (73.0%) .617
Two years of age (n = 439) 10 (5.4%) 7 (2.8%) .161
Second-hand smoke, n (%)
Inclusion (n = 485) 9 (4.1%) 44 (16.5%) <.001
Two years of age (n = 446) 1 (0.5%) 6 (2.4%) .124
Boys with asthma at 2 years of age 5 (4.7%) 39 (22.9%) <.001
Girls with asthma at 2 years of age 3 (3.6%) 13 (11.6%) .042
Current inhaled corticosteroids at 2 years of age (n = 453) 9 (4.6%) 46 (18.0%) <.001
Gestational age at birth < 370/7 weeks (n = 443) 8 (3.8%) 28 (11.9%) .002
*Defined as completed at least 3 years of schools after secondary school.
Table II. Reference values: morning salivary cortisol percentile levels (nmol/L) at inclusion*
Percentiles
2.5 5 10 25 50 75 90 95 97.5
Inclusion
Reference 4.5 9.7 12.5 18.2 23.7 40.1 58.3 119.6 222.1
95% CI 3.1-12.1 64.9-258.6
Two years
All 11.8 13.6 16.2 24.6 34.1 43.9 56.6 65.2 80.2
95% CI 12.1-15.2 60.5-73.1
Boys 9.0 12.7 15.5 23.7 31.8 42.2 51.7 62.8 74.8
95% CI 8.3-14.8 55.6-77.6
Girls 12.9 14.4 16.9 26.7 38.5 45.6 60.3 69.7 112.0
95% CI 12.6-16.5 62.0-162.1
*From the 199 infants in the reference group (0-13 months of age), and at the 2-year follow-up from all 379 children, stratified by sex (boys n = 220, girls n = 159).
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[available at www.jpeds.com]; weighted mean 36.9 nmol/L [95%
CI 34.7-39.2] vs 32.4 nmol/L [95% CI 30.5-34.3] and geo-
metric mean of 35.1 nmol/L [95% CI 32.4-38.0] vs 30.1 nmol/L
[95% CI 28.0-32.3], respectively; P < .003). Reference values
are therefore presented stratified for sex (Table II). The sex dif-
ference in cortisol levels was not associated with the higher fre-
quency of a doctor’s diagnosis of asthma in boys (results not
shown).
The Role of Acute Moderate-to-Severe
Bronchiolitis
Morning salivary cortisol levels were significantly higher in
infants with acute bronchiolitis than in infants in the refer-
ence group (Figures 4 and 6, with a weighted mean differ-
ence of 12.8 nmol/L [95% CI 7.4-18.1] that remained significant
after adjusting for age and sex (13.9 nmol/L [95% CI 8.1, 19.7];
P < .0001).
At 2 years of age, however, the weighted mean cortisol levels
were similar in the bronchiolitis (33.8 nmol/L; 95% CI 31.8-
35.7) and reference group (34.9 nmol/L,; 95% CI 32.6-37.2),
and are thus presented for all 379 children (34.3 nmol/L; 95%
CI 32.8-35.8).
The predictability of cortisol at inclusion for assignment to
the bronchiolitis or reference group is illustrated by a re-
ceiver operating characteristic diagram (Figure 8). The area
under the curve was 0.634 (95% CI 0.577-0.690). The cutoff
value of cortisol giving the highest sum of sensitivity and speci-
ficity is 36.9 nmol/L, giving a sensitivity of 51.6% and a speci-
ficity of 68.3%.
Neither breastfeeding, parental education, second-hand
smoke, weight, nor length was associated significantly with
salivary cortisol level at inclusion or at 2 years of age (results
not shown). Subgroup analyses of non-Caucasian vs Cauca-
sian parents could not be performed owing to low numbers
of non-Caucasian parents.
Discussion
Reference values based on the 5th-95th percentiles were esti-
mated in 199 children from a general population in infancy,
and at 2 years of age in 379 children including the same ref-
erence population as well as children who in infancy were hos-
pitalized with acute bronchiolitis. Salivary cortisol levels were
significantly higher at 2 years of age than in infancy in the ref-
erence group, were significantly higher in infants with bron-
chiolitis compared with the reference group, and in girls at 2
years compared with boys. However, age was not associated
significantly with morning salivary cortisol at either of the 2
time points.
We found generally higher values than salivary cortisol levels
reported as quartiles by Ivars et al10 in a Swedish infant popu-
lation. Although our median value of 23.7 nmol/L (at a mean
age of 6 months) was similar to the mean value of 24.6 nmol/L
at 6 months of age reported by Ivars et al, their median cor-
tisol levels varied from 5.1 to 10.9 nmol/L during infancy.
Similar to our reference group, the Swedish study recruited 130
infants from a general population, with 95-120 samples col-
lected each month through infancy, and both studies using the
same radioimmunoassay method.10,22 The differences in cor-
tisol levels may be related to the timing of salivary sampling.
In our study, parents sampled saliva as soon as possible after
first awakening after 6 am, before feeding, in contrast with the
Swedish parents who collected saliva samples at least 1 hour
after solid food, sleep, or crying and riding a car, and 30 minutes
after intake of liquids. In line with a circadian rhythm, Ivars
et al observed that early morning samples (between 7:30 and
9:30 a.m.) were higher than evening samples (between 6:30 and
9:30 p.m.).10 Using the same analysis protocol, values between
those found in the present study, and those found by Ivars et al
were reported by Stenius et al23 in 6-month-old infants (geo-
metric mean of 14.9 nmol/L) with salivary sampling within
one-quarter of an hour after awakening in the morning, and
before the first meal. Higher cortisol levels in samples taken
as soon as possible after awakening are supported by the de-
creasing cortisol levels observed in samples taken hourly from
8 to 10 a.m. in children older than 2 years of age participat-
ing in a Japanese study of 57 healthy 0.5 to 4.0-year-old
children.9 Compared with the higher reference values ob-
served in the present study, their defined lowest and upper limits
of the reference range in micrograms/dL—0.076 (equals
2.1 nmol/L) and 0.827 (equals 22.8 nmol/L), respectively—
may reflect that the samples were taken later during the day.
An awakening cortisol response, described as the period of cor-
tisol secretory activity in the immediate 45-60 minutes after
awakening,24 reaches a maximum about 30 minutes after
wakefulness.1 An awakening response is supported by a study
in infants at a mean age of 2 months, reporting a mean value
of 0.31 mg/dL (8.6 nmol/L) immediately after awakening and
Figure 4. Comparison of mean salivary cortisol levels, control
and bronchiolitis groups. Morning salivary cortisol (weighted
mean [95% CI]) levels given for children in the reference group
and bronchiolitis group at inclusion and at 2 years of age. The
cortisol levels in infants with acute bronchiolitis were signifi-
cantly higher than levels in the reference group in infancy and
the bronchiolitis follow-up group at 2 years (P < .0001). Weighted
mean within the bars.
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0.60 mg/dL (16.6 nmol/L) 30 minutes after awakening from at
least 30 minutes of sleep.25 Thus circadian rhythm, with highest
peaks in the morning, as well as awakening response, as
described by Michels et al26 in only 52% of children 5-11
years of age, may explain the higher values in the present
study.
The higher cortisol values among girls at 2 years of age in
our study is a novel finding, and may have several causes. Higher
cortisol levels in girls may be related to a more pronounced
cortisol awakening response compared with boys, as de-
scribed by Pruessner et al27 in 12 year-old children, or may be
explained partially by a prolonged “mini-puberty” in girls com-
pared with boys.28 Because salivary cortisol reflects the free
fraction of cortisol, our finding cannot be explained by a
higher level of corticosteroid-binding globulin. Similarly,
sex differences in cortisol levels could not be explained by
the higher frequency of a doctor’s diagnosis of asthma among
boys.
Higher morning salivary cortisol in infants with acute bron-
chiolitis suggests possible pathophysiological involvement of
cortisol in acute bronchiolitis, although cortisol levels could
not be used to classify infants into bronchiolitis or control
groups owing to the overlapping values, as illustrated by the
receiver operating characteristic curve and dot plots. The infants
had their first samples taken during moderate to severe acute
bronchiolitis,18 in line with higher cortisol values found with
severe disease that possibly reflects suppression of the Th1 re-
sponse, as described in RSV infection in infants.29
A possible limitation of our study was the skewed study
population, where approximately 89% of mothers in the ref-
erence group and 63% in the bronchiolitis group had higher
education compared with the national average of 48% of all
women between 25 and 50 years of age, according to Statistics
Norway.30 We found no association between parental educa-
tion and salivary cortisol levels. Another potential limitation
is the low proportion of successful collection of samples at both
study points, especially in the bronchiolitis group. However,
the high probability of a difference between ill and control
groups at inclusion and between the sexes at the follow-up when
both groups are analyzed together makes it likely that they
reflect true differences.
Owing to the high proportion of infants with detected RSV
during acute bronchiolitis, it was not possible to perform robust
analyses into the potential specific impact of RSV on salivary
cortisol level.
A potential shortcoming of salivary measurement is the rep-
resentativeness of a spot sample of a biomarker with known
diurnal variation.7 However, measuring morning salivary cor-
tisol may provide information about the hypothalamic-
pituitary-adrenal axis and capacity for reaching high peak values
that may be blunted by measuring a 24-hour or several hour
urinary value. Another potential source of variation, particu-
larly for the highest values, could be blood contamination.
However, other studies have shown that blood contamina-
tion has little impact on salivary cortisol measurements.31,32
Greater variations at the upper end of salivary vs serum cor-
tisol levels may be explained by the fact that salivary cortisol
is an ultrafiltrate of the free fraction of serum cortisol. If acute
stress or other factors lead to a surge of cortisol exceeding the
corticosteroid globulin binding capacity, it is possible that we
may find a higher relative increase in salivary vs total plasma
cortisol.33
Sampling time is likely to be crucial for salivary measure-
ments. We standardized the sampling to the best of our ability,
but cannot rule out potential deviations from the time of sam-
pling. However, our approach of asking parents to sample as
soon as possible after awakening reduces potential variation
in time. Also, we did only 1 sampling per child on each oc-
casion; thus, repeatability could not be assessed. However,
Nagakura et al9 found no significant day-to-day variation
between 3 samples taken at 4- to 8-day intervals.
Reference morning cortisol values in infants were 9.7 to
119.6 nmol/L (5th-95th percentile), compared with 11.8 to
80.2 nmol/L at 2 years. Sex-specific reference values may be
necessary, because girls at 2 years of age in the present study
had higher cortisol values than boys. Acute bronchiolitis in
infancy was associated with higher morning salivary values
during hospitalization, but seemed not to influence morning
cortisol levels at 2 years of age. ■
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Appendix
Methods: In each tube was a known amount of 125I-labeled
cortisol in Tris buffer, competing with the salivary cortisol to
be attached to antibody binding sites. The saliva was kept within
the tubes in a water bath at 37°C for 30 minutes before it was
poured out. Then, the tubes were rinsed with a predefined
amount of water and left upside down for a period until they
were put into a gamma counter. A standard curve for
comparison was produced from a cortisol calibrating sample
in the kit. The working range for the method is 0-2000 nmol/L
and 150 mL of saliva is required. The analytical sensitivity is
3.0 nmol/L.
Results: At 2 years of age, the geometric mean values of
morning salivary cortisol were 31.6 nmol/L (95% CI 29.5-
33.9) in the bronchiolitis group and 32.8 nmol/L (95% CI 30.1-
35.6) in the reference group.
Table III. Morning salivary cortisol (nmol/L)
Cortisol levels
Reference group Bronchiolitis group
Unadjusted weighted mean Age increase Unadjusted weighted mean Age increase
Infancy 28.7 0.7 41.5 −0.6
95% CI 25.1 to 32.4 −0.2 to 1.6 37.6 to 45.4 2.4 to 1.2
Two years 34.9 0.0 33.8 −0.4
95 % CI 32.6 to 37.2 −0.6 to 0.6 31.8 to 35.7 −1.0 to 0.3










No available cortisol any 
time point (n = 17);
no saliva (n = 14), insufficient
saliva (n = 3)
Cortisol measure in 
infancy (n = 199  )
Cortisol at 2 years (n = 222  )
Bronchiolitis group 
(n = 308)
No cortisol at 2 years 
(n = 86); no saliva (n = 67), 
insufficient saliva (n = 19)
Reference group 
(n = 223)
No cortisol measure in
infancy (n = 24);
no saliva (n = 14), insufficient 
saliva (n = 10)
Cortisol at 2 years (n = 157  )
No cortisol at 2 years
(n = 66); no saliva (n = 43),
insufficient saliva (n = 23)
Cortisol measure in 
infancy (n = 184  )
No available cortisol any 
time point (n = 96);
no saliva (n = 33), insufficient
saliva (n = 63)
No cortisol measure in 
infancy (n = 124);
no saliva (n = 62), insufficient 
saliva (n = 62)
Figure 1. Flowchart of inclusion. Entrance of subjects with available cortisol measurements.
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Figure 2. Morning salivary cortisol at inclusion, dot plot; each
dot representing an individual.
Figure 3. Sex distribution, morning salivary cortisol at inclu-
sion dot plot; each dot representing an individual.
Figure 5. Morning salivary cortisol at 2 years of age, dot plot;
each dot representing an individual.
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Figure 6. Morning salivary cortisol (weighted mean (95% CI)) are given for boys (blue bars) and girls (red bars) in infancy and
at 2 years of age. P-value is shown for difference between sexes when <0.05. Weighted mean are shown within the bars. Cor-
tisol levels were significantly higher for girls at 2 years of age.
Figure 7. Sex distribution, morning salivary cortisol at 2 years
of age, dot plot; each dot representing an individual.
Figure 8. Receiver operating characteristic (ROC) curve,
showing predictability for bronchiolitis by morning salivary cor-
tisol at inclusion.
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